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A B S T R A C T
Mammalian embryonic stem cells (ESCs) are characterized by an ability to self-renew and
give rise to each of the three germ layers. ESCs are a pluripotential source of numerous
primitive progenitors and committed lineages and can make stoichiometric decisions lead-
ing to either asymmetric or symmetric cell division. Several genes have been identified as
essential for maintenance of self-renewal, but few non-lineage specific genes have been
identified as essential for differentiation. We selected the chromatin factor Ctbp2 from
microarray data for its enriched expression in stem cells, in comparison to committed pro-
genitors. RNA interference (RNAi) was used to knockdown gene expression in mouse ESCs
and the potential for transduced cells to self-renew and differentiate was assessed in ESC
and mesodermal assays. Here, we demonstrate an important role for Ctbp2 in stem cell
maintenance and regulation of differentiation using an in vitro system. The knockdown
of Ctbp2 increases the prevalence of ESCs in culture, delays differentiation induced by LIF
withdrawal, and introduces developmental changes in mesodermal differentiation. A
model is presented for the importance of Ctbp2 in maintaining a balance in decisions to
self-renewal and differentiate.
 2009 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
C-terminal binding protein (CtBP) was identified because
of its interaction with the C-terminus of the adenovirus E1A
oncoprotein (Boyd et al., 1993; Schaeper et al., 1995). In adeno-
virus, CtBP represses E1A transcriptional activation and onco-
genesis (Sollerbrant et al., 1996). Detailed reviews of CtBP’s
isolation, evolutionary conservation across eukaryotes, and
biochemical activity have been published by Turner and
Crossley (2001) and Chinnadurai (2002). Briefly, CtBP proteins
are highly conserved across Drosophila, zebrafish, mice, and
humans. Drosophila CtBP (dCtBP) interacts physically and
genetically with the transcriptional repressors kruppel, knirps,
and hairy in early development (Hildebrand and Soriano,
2002). In Drosophila, CtBP2 also interacts with snail, which is
required for proper mesodermal development and cell fate
decisions (Hemavathy et al., 2004).
The two CtBP proteins in mice – CtBP1 and CtBP2 – differ in
expression, cellular localization, and regulatory role. Ctbp1 is
expressed throughout embryogenesis and into adulthood.
Ctbp2 is expressed in the forming placenta and is restricted
to embryogenesis (Furusawa et al., 1999). CtBP1 is cytoplasmic
and CtBP2 is found almost exclusively in the nucleus (Zhao
et al., 2006). Both mammalian CtBPs associate with Polycomb
proteins and complex with transcription factors to repress
genes involved in mouse development. They have roles that
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somewhat overlap but they have differing degrees of impor-
tance. Ctbp1 nulls are born in expected Mendelian propor-
tions. Ctbp2 nulls are embryonic lethal with developmental
abnormalities appearing by E10.5 (Hildebrand and Soriano,
2002). The primary causes of lethality are defects in placental
and yolk sac development. There is also an observed decrease
in Brachyury expression. CtBP2 appears to be the more critical
of the two CtBPs in embryonic development, as Ctbp1 nulls
with a heterozygous Ctbp2 background are not viable and
die around E15.5–18.5 (Hildebrand and Soriano, 2002).
CtBP2 interacts physically with key factors in the stem cell
regulatory network. SMAD6 recruitment of CtBP2 to repress
BMP-associated transcription has been demonstrated in vitro
and in vivo (Lin et al., 2003; Hassel et al., 2004). CtBP2 can also
bind SOX6 and repress transcription of Fgf-3 (Murakami et al.,
2001). Other stem cell-related transcription factors that associ-
ate with CtBP2 to co-repress transcription include the AML/
EVI1 oncoprotein, the Gata1-binding factor known as Friend
of Gata (FOG), the mesodermal and ectodermal-specific tran-
scription factor c-EF1, and Krupple-like factor 3 (KLF3) (Turner
and Crossley, 1998; Fox et al., 1999; Furusawa et al., 1999;
Holmes et al., 1999; Turner et al., 2003). Although these pro-
tein–protein interactions have been documented biochemi-
cally, there are few studies that describe the functional
importance of CtBP2 in mammalian embryonic development.
Based on the in vivo description of embryonic lethality in Ctbp2
nulls and heterozygotes and based on decreased expression of
Brachyury, we predict that Ctbp2 is important in early embry-
onic differentiation and proper mesodermal emergence. In this
study, we use ESC and blast assays, as in vitro proxies for the
blastocyst and mesoderm, respectively, with the objective of
providing an in vitro parallel of what happens developmentally
prior to E10.5 in a Ctbp2 null.
2. Results
2.1. Lentiviral-mediated RNA interference of CTBP2 is
efficient
Lentiviral RNA interference vectors were designed to
knockdown expression of Ctbp2 in mouse ESCs (mESCs). A
lentiviral RNAi vector against Oct4, provided by Dr. Natalia
Ivanova at Princeton University, was used to transduce
mESCs in order to generate a self-renewal control and lentiv-
iral vectors against Smarca4 were used to generate a cell-cycle
control. RNAi was successful with all vectors, however, the
vectors containing shRNA sequences designed against the
more 3 0 region of the open reading frame (ORF) were most
efficient. The Ctbp2-A vector, which targets the more 5 0 region
of the Ctbp2 ORF, decreased gene expression by a broad range
of 28–54% (Fig. 1A). The Ctbp2-B vector, which targets the
more 3 0 region of the ORF, decreased gene expression by a nar-
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Fig. 1 – (A) Real-time PCR (RT-PCR) confirmation of Ctbp2 RNAi, as compared to empty vector (EV) and Oct4 RNAi positive
control. The Ctbp2-A RNAi construct targets a more 5 0 region of the open reading frame (ORF) of Ctbp2 and the Ctbp2-B RNAi
construct targets a more 3 0 region of the ORF of Ctbp2. Gene expression is the average per timepoint from two independent
experiments. (B) Western blots to confirm knockdown of CtBP2 protein in uninfected (Un), empty vector (EV), Ctbp2-A RNAi (C-
A) and Ctbp2-B RNAi (C-B) cultures. Antibodies used against whole cell extracts from cultures at Day 12 (left) and Day 15 (right)
post-transduction (p.t.). Each blot represents an independent experiment. ERK-1/2 is used as input control.
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rower and more specific range of 85–98% (Fig. 1A). The Oct4
RNAi control decreased gene expression consistently by
75%, which is sufficient to recapitulate the in vitro and
in vivo phenotypes. The efficiency of CtBP2 knockdown was
confirmed with Western blots of whole cell extracts from cells
sorted into media at Days 12 and 15 post-transfection. Blots
show that there is no observable change in CtBP2 with
Ctbp2-A RNAi, however, there is a clear knockdown of CtBP2
observed with Ctbp2-B RNAi (Fig. 1B). The Western blot data
is consistent with the quantification of each vector’s ability
to knockdown Ctbp2, as measured by RT-PCR.
2.2. Self-renewing ESCs are more prevalent in the absence
of CtBP2
After confirming the efficiency of CtBP2 knockdown,
transduced ESCs were placed in a competition assay to char-
acterize self-renewal ability. The premise of the assay, as de-
scribed in more detail in Section 4, is to monitor the ratio of
GFP/GFP+ ESCs over time. The competition assay was read
using FACS at 48-h intervals that overlapped with culture
passage. The raw percentage change in GFP/GFP+ is de-
picted in Fig. 2A and was normalized against the mock in-
fected and empty vector cultures to adjust for an expected
10% decrease in cells. Our findings are based on cumula-
tive changes in GFP/GFP+ from Day 2 through Day 14 of
competition and indicate that a knockdown of CtBP2 causes
an increase in the ratio of GFP/GFP+ cells (Fig. 2A). The ex-
tent of the phenotype is related to the degree of RNAi asso-
ciated with the Ctbp2-A and Ctbp2-B vectors. In Ctbp2-A
RNAi cultures, 45–80% of Ctbp2 is expressed but without
change to protein levels. The absence of change in protein
levels is associated with an insignificant increase in the
GFP ratio (p > 0.05) (Fig. 2A). In contrast, Ctbp2-B RNAi
reduces Ctbp2 expression to less than 15% and there is an
observable loss of protein. This loss of protein is associated
with a significant (p < 0.05) 20% increase in the GFP ratio
(Fig. 2A).
Fig. 2 – ESC self-renewal and maintenance. (A) Percent change in RNAi GFP+ ESCs in competition with GFP ESCs as
measured by FACS. Percent change is cumulative and measured from Day 2 through Day 14 of a timecourse with empty vector
(EV), Ctbp2-A RNAi, Ctbp2-B RNAi, and Oct4 RNAi cultures. Data presented is the average from four independent experiments.
(B) Proliferation assay for a 36-h culture period with empty vector (EV), Ctbp2-A RNAi, Ctbp2-B RNAi, Smarca4-A RNAi and
Smarca4-B RNAi cultures. Data presented is the average from four independent experiments.
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Since Ctbp2-B RNAi cells experience an apparent gain in
self-renewal ability and increased prevalence in culture, then
the assumption is that either the progression through the cell
cycle quickens or the balance between asymmetric and sym-
metric self-renewal is altered. To explore the former possibil-
ity, we performed PKH26 dye and Annexin V staining assays
using Smarca4 RNAi cultures as a positive control. We did
not observe significant cell cycle-related changes in Ctbp2
RNAi cultures although it was apparent that independent cul-
tures of Ctbp2-B RNAi ESCs produce greater numbers of ESCs
over time. In a proliferation assay with Ctbp2-B RNAi, we did
not observe a significant (p > 0.05) increase in cell division
(Fig. 2B) or change in STAT3 and AKT signaling (Supplemen-
tary materials, Fig. S1). In the absence of data in support of in-
creased cell division in Ctbp2 RNAi ESCs, we turned to assays
that would explore the possibility of a shift in self-renewal
and differentiation.
We used three methods to characterize self-renewal and
differentiation – AP assay, colony measurements, and LIF
withdrawal. An increase in the self-renewal ability of ESCs
should affect colony morphology and maintenance. Changes
in colony morphology can be visualized in an alkaline phos-
phatase (AP). In the AP assay for Ctbp2 RNAi, we analyzed
the morphology of Ctbp2-B RNAi ESCs in LIF+ (self-renewal)
and LIF (differentiation) conditions. In the presence of LIF,
we observed Ctbp2-B RNAi colonies that were larger in com-
parison to the controls and in comparison to Ctbp2-A RNAi
(Fig. 3A). We used IPLab software to trace colony boundaries
and to select the pixels at colony boundaries to generate
measurements of perimeter and area. Our findings of larger
colony area and perimeter for Ctbp2-B RNAi cultures confirm
the results of the AP assay (Fig. 3B). In the AP assay in the ab-
sence of LIF, differentiation ensues as expected in all cultures
except for Ctbp2-B RNAi. In the Ctbp2-B RNAi cultures, large
round colonies are still visible in contrast to mock, empty vec-
tor (EV), Ctbp2-A RNAi and Oct4 RNAi cultures (Fig. 3A). This
difference in colony morphology of Ctbp2-B RNAi is consistent
with the demonstrated difference in degree of gene expres-
sion knockdown and significance of competition ratios. The
morphological observation in the LIF panel of the AP assay
is supported by analysis of Oct4 levels during a LIF withdrawal
timecourse. In the AP assay when LIF is removed, Ctbp2-B
RNAi cultures do not differentiate as quickly as control cul-
tures (Fig. 3A, compare LIF to No LIF). After 7 days without
LIF, the EV cultures can be categorized as ‘‘differentiated’’
and the Ctbp2-B RNAi cultures resemble the ‘‘semi-differenti-
ated’’ cultures pictured in Ivanova et al. (2006). The morpho-
logical delay in differentiation is confirmed by a
corresponding delay in decrease of Oct4 expression after LIF
withdrawal. In Fig. 3C, we show that Oct4 levels decrease
sharply and as expected in empty vector cultures by Day 4
of LIF withdrawal, whereas Oct4 levels in Ctbp2-B RNAi cul-
tures do not decrease sharply and are not at comparably
low levels until Day 6 of differentiation.
Fig. 3 – (A) Alkaline phosphatase (AP) assay of ESCs in self-renewal (LIF+, top) and differentiation (LIF, bottom) conditions.
Cells were sorted for GFP expression at Day 2 post-transduction (p.t.), plated in their respective conditions at Day 4 p.t., and
assayed at Day 9 p.t. (B) Average size of colonies from Ctbp2-A RNAi (n = 15) and Ctbp2-B RNAi (n = 11) cultures in comparison
to mock infected (Mock, n = 20) and empty vector (EV, n = 14) cultures, as measured using IPLab software. (C) Expression
timecourse of Oct4 in empty vector (EV) and Ctbp2-B RNAi cultures, measured by RT-PCR, after differentiation induced by LIF
withdrawal at Day 0.
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2.3. Blast colony formation is delayed in Ctbp2 RNAi
cultures
Our findings in ESC self-renewal assays demonstrate that a
decrease in CtBP2 affects stem cell maintenance by increasing
the prevalence of ESCs in culture and shifting cell fate deci-
sions away from differentiation. We wanted to further charac-
terize the impact of Ctbp2 RNAi on differentiation and chose
mesodermal differentiation assays given reported in vivo
changes in yolk sac development and Brachyury expression
in the null (Hildebrand and Soriano, 2002).
The transferability and efficiency of RNAi in the in vitro
mesodermal differentiation assays was verified using a
proof-of principle experiment targeting Aml/Runx1. In vivo,
Aml/Runx1 is required for the development of definitive, but
not primitive, hematopoietic lineages from the hemangio-
blast (Okuda et al., 1996; Wang et al., 1996). Lentiviral-medi-
ated RNAi against Aml/Runx1 recapitulates the in vivo
phenotype and results in normal primitive and blocked defin-
itive hematopoiesis (Supplementary materials, Fig. S2A). The
RNAi vector is stable in the hemangioblast system and
expression from the RNAi cassette is maintained throughout
mesodermal induction and differentiation (Supplementary
materials, Fig. S2B). We used the Ctbp2-B RNAi vector for the
experiments in the hemangioblast system because this vector
yielded the highest level of knockdown and the most signifi-
cant results in the ESC assays.
Formation of mesodermal progenitors, known as heman-
gioblasts (in vivo) or blast colonies (in vitro) is delayed in
Ctbp2-B RNAi cultures (Fig. 4A). Upon differentiation and dur-
ing the blast formation window of Days 2.5–3.5, C-KIT expres-
sion should decrease and FLK-1, a marker for blast colonies,
should increase. At Day 3.5 when blast colony formation is
expected to peak, C-KIT expression should rebound because
c-kit is necessary for hematopoietic development. CD31
expression should decrease through Day 3.5. The pattern of
marker expression at Day 3.5 is very specific and critical be-
cause it predicts the emergence of the in vitro hemangioblast
(Lacaud et al., 2004). Blast colonies can only form properly if
self-renewal has been sufficiently suppressed. A temporal
comparison of the empty vector cultures (EV RNAi) and
Ctbp2-B RNAi shows a clear half-day delay in kinetics, even
though EV RNAi and Ctbp2-B RNAi cultures are similar at
Day 0 (Fig. 4B). This confirms that neither has entered differ-
entiation prematurely. A snapshot of FACS kinetics at Day 3.5
shows that EV RNAi has the expected expression pattern of
FLK-1 and C-KIT expression and that CD31 expression has de-
creased as expected (Fig. 4A). In contrast, the C-KIT expres-
sion in Ctbp2-B RNAi has not rebounded and the expression
of CD31 is lagging in its descent. Quadrant statistics on bio-
logical replicates of the FACS timecourse confirm that the dif-
ferences in FLK-1 and C-KIT expression between EV RNAi and
Ctbp2-B RNAi at Days 2.5, 3, and 3.5 are significant (p < 0.05)
with the largest difference at Day 3.5 (Fig. 4B). CD31 expres-
sion is also significantly different between the two popula-
tions at Days 3 and 3.5 (Fig. 4B, p < 0.05).
The FACS kinetics for expression of FLK-1, C-KIT and CD31
define the window of blast colony formation, but the colony-
forming assays confirm blast colony emergence during this
window. The morphology of the blast colonies and blast pre-
cursors (secondary EB and transitional) do not differ between
normal and RNAi cultures (Supplementary materials, Fig. S3).
We found that there are significantly more (p < 0.05) mesoder-
mal progenitor colonies in Ctbp2-B RNAi cultures at Day 3.5
with the largest difference in the Flk+ sorted population
(Fig. 5A). It is important to note that the Flk+ population gives
rise to the blast colony; however, when we characterized the
colonies according to type we found that although Ctbp2-B
RNAi has a larger total number of colonies, it has a much low-
er number of mature blast colonies. The bulk of the total col-
ony count consists of immature transitional colonies and
undifferentiated secondary EBs (Fig. 5B).
If we look at the distribution of the three colony types
(blast, transitional and secondary EB) over time, we can char-
acterize a difference in the pattern and distribution of blast
colony emergence with a significant difference (p < 0.05) in
the number of blast colonies at Day 3.5 in Ctbp2-B RNAi
(Fig. 6). The EV RNAi cultures peak in blast formation at Day
3.5, as expected, but the Ctbp2-B RNAi cultures do not experi-
ence a peak in blast colony formation until Day 4. At the time
of EV RNAi peak (D3.5), blast colonies represent roughly 60%
of total colonies, but at the time of Ctbp2-B RNAi peak (D4),
blast colonies are in the minority at approximately 30% of to-
tal colonies. The kinetics of Brachyury expression, conducted
in quadruplicate, correlate well with the FACS profiles. Brachy-
ury expression in EV RNAi peaks at Day 3 of mesodermal
induction and precedes the point of hemangioblast formation
at Day 3.5, as expected (Fig. 7). Brachyury expression in Ctbp2-B
RNAi is down regulated and expression does not reach its ze-
nith until Day 3.5. This half-day delay in Brachyury expression
goes hand-in-hand with the significant half-day delay in
emergence of blast colonies.
2.4. The distribution of colonies in early hematopoiesis is
altered
In the hematopoietic ‘‘big mix’’ assay of Ctbp2-B RNAi cul-
tures, there are more total colonies but there is no significant
difference in the absolute number of hematopoietic colonies
(primitive erythroid, macrophage, erythroid-macrophage,
and mixed lineage). There is a clear difference in the distribu-
tion of colonies in Ctbp2-B RNAi, with the number of second-
ary EBs dominating the total colony distribution and dwarfing
the number of hematopoietic colonies (Supplementary mate-
rials, Fig. S4B). In addition to a relative deficiency in hemato-
poietic colonies, which characterize in vitro hematopoiesis,
we also characterized a deficiency in Scl expression in
Ctbp2-B RNAi (Supplementary materials, Fig. S4A).
3. Discussion
In this study, our goal was to explore the effect of loss of
CtBP2, in vitro, in order to better characterize the observed
in vivo defects that arise between E6.5–E10.5, prior to embry-
onic lethality. ESC assay results described herein provide an
in vitro view of null embryonic development and demonstrate
that although the defect in null mice is not fully visible until
E10.5, there are important and progressive changes in the
developmental program from the blastocyst to gastrulation
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stages. There are also important changes to the development
of the hemangioblast. The hemangioblast does not represent
the mesoderm, per se, but does represent the potential of the
mesoderm to progress through development and give rise to
differentiated cells.
This study focused primarily on characterizing Ctbp2
knockdown culture development from ESC (blastocyst) to EB
(gastrula) and then on the emergence and function of the
blast colony (hemangioblast). A functional approach was used
to characterize the effect of a loss of Ctbp2 in ESC mainte-
nance and in the development of mesodermal progenitors.
Findings indicate that a knockdown of Ctbp2 expression
skews the balance between self-renewal and differentiation
towards self-renewal even when differentiation is forced. A
Fig. 4 – Delay in hemangioblast formation. (A) FACS profile of embryoid body (EB) differentiation in empty vector (EV) and
Ctbp2-B RNAi cultures at Day 0 (left) and Day 3.5 (right). (B) Percent differences between Ctbp2-B RNAi EBs and EV RNA EBs in
FLK-1/C-KIT (top) and CD31 (bottom) FACS expression at D2.5, D3, D3.5, and D4. Data represents the timepoint averages from
three independent experiments.
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competition assay was first used to quantify an increase in
prevalence in ESCs in the absence of Ctbp2 and then cell cycle
assays verified that this change is not attributable to changes
in rate of cell division. Since there are only two mechanisms
by which a stem cell could increase in prevalence, these being
to divide more rapidly or to experience a change in symmetry
of fate decisions, it was hypothesized that the latter
mechanism was responsible for our observations. The
hypothesis was supported by results from the AP assay in
LIF conditions and the quantification of Oct4 expression in
a differentiation timecourse. These results lead to the conclu-
sion that Ctbp2 is important for normal asymmetric differen-
tiation. A decrease in CtBP2 creates a noticeable delay in ESC
differentiation, but it does not completely block differentia-
tion as evidenced by our ability to generate embryoid bodies.
However, the embryoid bodies with knocked down Ctbp2
Fig. 5 – (A) Total number of blast assay colonies from a FLK+ population isolated from embryoid bodies (EBs) at Day 3.5. Data is
representative of cultures in triplicate with p < 0.05. (B) Distribution of type of blast assay colony, generated from a FLK+
population isolated from EBs at Day 3.5, according to standard morphologies for secondary EB, transitional, or blast colonies.
Empty vector (EV) is pictured in black and Ctbp2-B RNAi (Ctbp2) in grey. Cells from Day 3.5 EBs were isolated prior to sorting
and according to GFP expression only (Pre), from sorting according to GFP and Flk-1 expression (FLK+), and from sorting
according to GFP expression and the absence of Flk-1 expression (FLK). Data is representative of cultures in triplicate with
p < 0.05.
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expression are not normal. Emergence of blast colonies from
Ctbp2-B RNAi EBs is delayed. In vitro, the expectation is to iso-
late the highest number of mesodermal progenitor colonies,
or blast colonies, from EBs that are at Day 3.5 of differentia-
tion but in the absence of Ctbp2, peak blast formation is de-
layed until Day 4. The timing of this isolation is critical as
primitive hematopoiesis rides on the coat tails of blast forma-
tion and what might appear to be a small delay of 12 h is sig-
nificant for the rapidly developing embryo.
In addition to a delay in blast formation, there is a signif-
icant accumulation of immature blast colony precursors. If
differentiation occurred normally, then the expectation is to
isolate a larger number of differentiated blast colonies from
Ctbp2-B RNAi. Transitionals, defined in Robertson et al.
(2000) as colonies containing cell populations undergoing
commitment from mesoderm to hematopoietic and endothe-
lial lineages, should be in the minority by Day 3.5. Instead
with Ctbp2-B RNAi, there are a proportionally smaller number
of mature blast colonies and a larger number of immature
transitional and secondary EB colonies. Additionally, if the
blast colonies that emerged from Ctbp2-B RNAi EBs were nor-
mal, then in the hematopoietic assay the total number of
primitive and definitive hematopoietic colonies should have
greatly surpassed those of EV RNAi. Instead the numbers of
hematopoietic colonies are comparable to EV RNAi but only
make up 10% of the total colonies in Ctbp2-B RNAi.
Gene expression data and results of Western blots for sig-
naling molecules can be used in conjunction with existing
knowledge to build a mechanistic model for Ctbp2 in embry-
onic development. In addition to characterizing functional
delays in differentiation, this study found changes in Oct4,
Brachyury and Scl expression. Abnormal changes in protein
Fig. 6 – Distribution of secondary embryoid body (EB), transitional and blast colonies across Days 2.5–6. The significant
difference (p < 0.05) in blast colonies between empty vector (EV, top) and Ctbp2-B RNAi (bottom) at D3.5 noted by asterisk (*).
Distribution at each timepoint is representative of triplicate cultures. Data at D4 and D6 represents triplicate cultures in two
independent experiments and data at D3 and D3.5 represents triplicate cultures in three independent experiments.
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levels and phosphorylation were not evident in STAT3 or AKT
signaling or in levels of phosphorylated GSK3-b and b-catenin.
STAT3 is phosphorylated in response to an activating signal
induced by the LIF ligand. We see normal STAT3 availability
and phosphorylation in LIF+ conditions and the expected loss
of phosphorylation in LIF conditions. Although cultures
lacking CtBP2 lose STAT3 phosphorylation upon LIF with-
drawal, they retain Oct4 expression well into induced differ-
entiation. This retention of Oct4 expression is attributed as
the mechanism behind the Ctbp2-B RNAi cultures’ self-renew-
al resiliency in the absence of LIF. Since CtBP2 is a transcrip-
tional co-repressor, it would be worth exploring in future
biochemical studies whether there is a physical binding of
CtBP2 to the Oct4 promoter or if CtBP2 is repressing Oct4 by
binding to other genetic elements or co-activators.
A recent study reports that STAT3 and AKT pathways
make up a parallel circuit for maintaining self-renewal in
ESCs in the absence of LIF (Niwa et al., 2009). We were able
to exclude STAT3 signaling as a potential mechanism for
the Ctbp2-B RNAi phenotype and in our analysis of AKT sig-
naling in the presence of LIF, we do not observe a change in
protein or phosphorylation levels. This study does not ex-
clude the potential for an AKT-associated signaling mecha-
nism in Ctbp2-B RNAi cultures in the absence of LIF
(Supplementary materials, Fig. S1C). However, given our iden-
tification of both a gain of function phenotype in the presence
of LIF and a downward trajectory of Oct4 expression after LIF
withdrawal, the signal regulating CtBP2’s repressor activity
should be apparent in both the presence and absence of LIF.
The phenotypes observed in the blast assays, namely a de-
lay in blast colony emergence and an unusual abundance of
transitional colonies, are attributed to a loss of Brachyury
and Scl. These in vitro findings parallel those from in vivo em-
bryos with defects in Brachyury expression and from Scl/
EBs (Robertson et al., 2000). A decrease in Brachyury expres-
sion was noted in the Ctbp2 null and linked to Wnt signaling,
since CtBP2 is reported to function with b-catenin as a
transcriptional activator of Brachyury (Yamaguchi et al.,
1999; Hildebrand and Soriano, 2002). Our study does not find
a change in GSK3-b or b-catenin levels in the absence of
CtBP2, therefore, we can confirm that CtBP2 functions along-
side b-catenin instead of functioning upstream of b-catenin.
We can conclude that CtBP2 is required for normal transcrip-
tion of Brachyury and that Wnt signaling alone is necessary
but not sufficient to activate normal transcription of Brachyu-
ry. There are no published findings with regard to CtBP2 regu-
lation of Scl; however, defects in yolk sac vascularization are
noted in the Ctbp2 null (Hildebrand and Soriano, 2002). Scl is
recognized as a key regulator of hematopoietic specification
and yolk sac angiogenesis, so the in vivo hematopoietic de-
fects and the abundance of transitionals in vitro point toward
a loss of Scl (Robertson et al., 2000; Lecuyer and Hoang, 2004).
Gene expression analysis confirms a decrease in expression
of Scl in Ctbp2-B RNAi and leads to the conclusion that Ctbp2
is important in embryonic development as a transcriptional
activator of Scl. Protein–protein interactions and promoter
studies are still needed to characterize CtBP2’s effect as a di-
rect activator or as an indirect activator of Scl gene
expression.
The decision to self-renew or differentiate is not as black
and white as it might appear and this existence of a gray area
enables ESCs to respond to the constantly changing demands
of development. Pluripotency depends on an ability to bal-
ance fates and choose between symmetric self-renewal,
asymmetric cell division, or commitment. The findings from
this study demonstrate a clear role for Ctbp2 in embryonic
development. The model proposed is one in which CtBP2 nor-
mally represses Oct4, either directly or via a yet to be deter-
mined signaling pathway, to permit ESC differentiation and
maintain asymmetric self-renewal. The model also proposes
that CtBP2 directly activates transcription of Brachyury and
Scl to permit normal blast formation and induction of
hematopoiesis.
The proposed role of CtBP2 is to establish a pattern of gene
expression that favors pluripotency and asymmetric self-re-
newal. The loss of CtBP2 does not completely block differen-
tiation in ESC or blast assays and does not completely block
transcription of Brachyury or Scl, which suggests the presence
of a secondary transcriptional activator with similar function.
From a developmental perspective, the presence of a second-
ary regulator in the absence of CtBP2 will only rescue the
developing embryo if the activity occurs in parallel or if nor-
Fig. 7 – Expression of Brachyury in embryoid body (EB) differentiation. Quantified for empty vector (EV) and Ctbp2-B RNAi
(Ctbp2) cultures using RT-PCR.
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mal expression of Brachyury and Scl is maintained. Given the
observed in vivo defects which lead to embryonic lethality
and the delays in the in vitro assays that lead to aberrant
ESC differentiation and blast formation, we infer that the sec-
ondary regulatory does not function in parallel to CtBP2, but
rather, is activated in response to a loss of CtBP2. In sum,
the Ctbp2-B RNAi cultures do eventually differentiate but
unfortunately, with regard to embryonic development, delays
in developmental cues are often lethal. In addition to contin-
ued characterization of biochemical interactions between
CtBP2 and stem cell gene promoters to further our knowledge
of the developmental regulation in the in vivo null, the finding
of an abundance of undifferentiated progenitors also suggests
that future studies include an analysis of Ctbp2 in tumor
models.
4. Experimental procedures
4.1. Candidate selection and RNA interference design
Ctbp2 was selected from microarray expression data sets
based on differential expression (enrichment) in stem cells,
in comparison to committed progenitors (Ivanova et al.,
2002; Ramalho-Santos, 2002). The criteria used were identifi-
cation as a chromatin factor and a greater than twofold level
of enrichment in stem cells. Ctbp2 satisfied both criteria suffi-
ciently as a chromatin-related co-repressor of transcription
with a level of expression in mouse embryonic stem cells five
times that measured in committed progenitors (Ivanova et al.,
2002).
Dharmacon’s RNAi design program (http://www.dharma-
con.com/sidesign) was chosen based on specificity in the de-
sign of siRNA sequences and use of the National Institutes of
Health (NIH) Blast algorithm to exclude sequences with any
homology to Ctbp2. Blast of Ctbp1 and Ctbp2 shows 76% se-
quence homology. Blast of the siRNA sequence Ctbp2-A to
the coding sequence of Ctbp2 shows pairing of all 19 nucleo-
tides at position 1924–1942. There are six additional pairings
possible but the largest of these is only 8/19 nucleotides. Blast
of the siRNA sequence Ctbp2-A to the coding sequence of
Ctbp1 shows the largest match as only 9/19 nucleotides, with
an additional seven pairings of no more than 8/19 nucleo-
tides. Blast of the siRNA sequence of Ctbp2-B to the coding se-
quence of Ctbp2 shows pairing of all 19 nucleotides at position
2594–2612. There are an additional four pairings possible but
the largest match is only 9/19 nucleotides. Blast of the siRNA
sequence Ctbp2-B to the coding sequence of Ctbp1 shows that
there is only one possible pairing of 7/19 nucleotides.
Some publications have suggested an effect of the anti-
sense strand of the siRNA construct, so to be cautious, we
blasted this sequence as well. Our findings show that the
anti-sense sequence of Ctbp2 construct A with the Ctbp2 cod-
ing sequence yields one match of 7/19 while a blast of the
same construct with the Ctbp1 coding sequence yields three
pairings, all of 8/19 base pairings or less. The anti-sense se-
quence of Ctbp2 construct B blasted against the Ctbp2 coding
sequence produces six matches of 8/19 base pairings or less,
and a blast of the same construct with the Ctbp1 coding
sequence yields only one match of 7/19 base pairings. The
conventional minimum threshold for bioinformatics exclu-
sion is less than 15 base pairs of homology. The homology
of the additional pairings shown here is far below that thresh-
old. Jackson et al. (2003) tested the thresholds at which siRNA
becomes ineffective and their findings affirm 15 base pairs of
homology as the threshold.
4.2. Lentiviral vector production and RT-PCR for gene
expression
A third generation lentiviral vector FUGW (Lois et al., 2002)
was modified as described in Ivanova et al. (2006) to express a
short-hairpin RNA (shRNA) from an H1 promoter. Sequence-
specific RNAi cassettes were designed in part using Dharma-
con’s siRNA Design Center. The Dharmacon software was
used to, first, identify a gene specific target within the open
reading frame (ORF) and, second, to generate a 19 base, se-
quence-specific oligonucleotide. Two shRNA cassettes were
generated per gene target. The cassette that targeted the
more 5 0 region of the ORF was labeled ‘‘A’’ and the cassette
that targeted the more 3 0 region of the ORF was labeled ‘‘B’’.
The oligonucleotides generated are as follows: Ctbp2-A (ATTC
GACAGTCTGCCACAT) and Ctbp2-B (AGAATTCTTCGTGACT
TCA). The shRNA cassettes were cloned directionally into
the vector using XbaI and SmaI cloning sites. Cloning was ver-
ified by restriction digestion with PacI and sequencing of the
fragment product with a primer for the HIV-1 flap (ACA-
GCAGAGATCCAGTTTG). Each sequence-verified shRNA len-
tiviral plasmid was co-transfected with pVSV-G and
pCMVd8.9 packaging plasmids into 293FT cells. At 16–22 h
prior to co-transfection, the 293FT cells were plated on pre-
gelatinized 15 cm dishes at 18 · 106 cells per dish and cultured
at 37 C. At transfection, 3–15 cm dishes of cultured 293FT
cells were used per lentiviral construct. Superfect was used
to mediate transfection and the transfected 293FT cells were
cultured at 37 C for 20–24 h and moved to 32 C for an addi-
tional 40–44 h of culture. The viral supernatant was harvested
from the dishes, filtered through a 0.44 lm low-protein bind-
ing filter, and centrifuged for 150 min at 50,000g. The resulting
pellet was resuspended in 300 lL sterile PBS, aliquoted, and
stored at 80 C until use. Viral titers were measured using
serial dilutions of viral construct to transduce NIH 3T3 fibro-
blasts and then FACS analysis measured expression of GFP
to confirm transduction efficiency. For quantification of RNAi
efficiency in gene expression knockdown, all transduced ESCs
were sorted by FACS, according to expression of GFP, into Tri-
zol for RNA extraction and cDNA synthesis. Quantitative poly-
merase chain reaction (Q-PCR) was conducted on cDNA
samples from cells sorted on Days 4, 8, 11 and 12 post-trans-
duction (p.t.).
4.3. Cell culture
CCE murine ES cells (Advanced Cell Technologies) were
maintained on gelatinized plates in self-renewal media
(DMEM supplemented with 10% FCS, glutamine, non-essen-
tial amino acids, sodium pyruvate, BME, P/S, and LIF). J1 mur-
ine ES cells (a gift from Dr. Gordon Keller, Mt. Sinai School of
Medicine) were cultured on irradiated mouse primary embry-
onic feeders as reported (D’Souza et al., 2005). Transductions
were performed as follows: CCE ES cells were trypsinized
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and resuspended to a concentration of 400,000 cells/mL in
CCE self-renewal media supplemented with polybrien. For
each vector, 1 mL of cells was mixed with the lentiviral RNAi
construct at low multiplicity of infection (MOI of 5), plated in
one well of a pre-gelatinized 6-well dish, and cultured at 37 C
for 20–24 h. After the first 20–24 h period, 1 mL of new CCE
self-renewal media was added to each well of the dish and
the dish was cultured for an additional 24 h to maximize
GFP expression from the lentiviral construct. J1 cells were
transduced in a similar fashion except for the inclusion of a
feeder depletion step, on an ungelatinized dish for 1–1.5 h,
prior to the addition of lentiviral RNAi construct.
4.4. Quantitative and semi-quantitative PCR
Cells were sorted into Trizol at a concentration of
100,000 cells/mL. Total RNA was extracted using a standard
RNA isolation protocol. Total RNA was transcribed into cDNA
with random hexamers using Powerscript. Semi-quantitative
































For Western blotting, whole cell proteins were isolated
with RIPA buffer and nuclear proteins were isolated with
TMSB buffer (25 mM NaCl, 10 mM Tris–HCl at pH 7.8, 1.5 mM
MgCl2, 0.25 M sucrose, 10 mM BME, 0.5 mM PMSF) and F buffer
(10 mM Tris, pH 7.05, 50 mM NaCl, 30 mM sodium pyrophos-
phate, 50 mM NaF, 5 lM ZnCl2, 0.1 mM Na3VO4, 10% glycerol,
0.1% Triton X-100, aprotinin, PMSF). After SDS–PAGE, the
nitrocellulose was blotted with antibodies to CtBP2 (Santa
Cruz #5967), Phospho-STAT3 (Cell Signaling Technologies
#9138), STAT3 (Cell Signaling Technologies #9139), Actin (Sig-
ma #A2066), SMARCA4 (Upstate #07-478), Phospho-AKT Path-
way Sampler kit (Cell Signaling Technologies #9916), MAPK/
ERK-1/2 (Cell Signaling Technologies #9102), b-catenin (a gift
from Dr. Kateri Moore, Princeton University), and ERK-1/2 (a
gift from Dr. Jean Schwarzbauer, Princeton University).
4.6. Competition and proliferation assays
Transduced cells were sorted on a FACS Vantage according
to GFP expression. GFP-positive cells were plated into compet-
itive assays, in a 6-well dish at 37 C as described in detail in
Ivanova et al., 2006. Cultures were analyzed for GFP expres-
sion by FACS at each 48-h passage. Briefly, the ESC competi-
tion assay has been used in previously published studies to
assess self-renewal ability (Ivanova et al., 2006; Galan-Caridad
et al., 2007) and is based on the classic hematopoietic stem
cell (HSC) competitive repopulating assay. Normal stem cells,
GFP, set the threshold for self-renewal and differentiation
activity in culture. Mutant ESCs, GFP+, are placed in self-re-
newal competition with the normal ESCs. The ratio used for
most competition assays is 50% normal ESCs and 50% mutant
ESCs. If the mutation or knockdown in the mutant ESCs has
no affect on self-renewal ability, then the ratio of 50/50, as as-
sayed by FACS for GFP/GFP+, will be maintained over the
course of the culture period (+). If the mutation leads to a loss
of ESC self-renewal ability, then the mutant ESCs will differ-
entiate and will not be included in the GFP+ stem cell cate-
gory. Differentiated ESCs are larger and can be separated
out from undifferentiated ESCs according to FACS scatter pro-
file. The resulting ratio will favor a higher percentage of nor-
mal stem cells (GFP) as the dominant cell type in the
culture. If the mutation leads to a gain of self-renewal ability
above what is normally observed in normal cultures, then the
ratio of GFP/GFP+ ESCs will shift towards the GFP+ cell pop-
ulation. We used internal controls to ensure that the differ-
ence in GFP/GFP+ is not attributable to transfection
reagents, handling (mock transfection) or to RNAi method
(empty vector). We also used a positive control for loss of
self-renewal (Oct4 RNAi).
To ascertain rate of proliferation, cultures were first ana-
lyzed using PKH26 dye retention (Sigma) and Annexin V stain-
ing (Roche) according to manufacturer’s instructions to
exclude the likelihood of abnormal changes in cell cycle or rate
of apoptosis. Afterwards, control and knockdown cells were
grown in separate dishes with cell counts at passage, every
36-h, for four passages. For each passage, we first counted the
cell number in culture for the previous passage and then we re-
plated a specific number of cells (identical number for both
control and knockdown cultures) so that each passage began
with the same cell number per culture dish.
4.7. Differentiation
For the alkaline phosphatase (AP) assay, ESCs were sorted
at Day 2 post-transduction and plated in LIF+ or LIF condi-
tions in DMEM supplemented with 10% FCS (tested for ESCs),
glutamine, non-essential amino acids, sodium pyruvate, BME,
and P/S as reported (Ivanova et al., 2006). Cultures were
stained and assayed using an AP kit (Sigma) at Day 9 post-
transduction and colony size was measured with IP Lab
(Scanalytics Inc.) software.
For embryoid body (EB) differentiation, ESCs were differen-
tiated under EB-generating conditions in DMEM, 10% FCS
(tested for differentiation), glutamine, non-essential amino
acids, sodium pyruvate, BME, and P/S. EBs were trypsinized
and dissociated prior to analysis by FACS with antibodies
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against FLK-1 (a gift from Dr. Gordon Keller, Mt. Sinai), PE-con-
jugated C-KIT (BD Pharmingen #553355), and biotin-conjugated
CD31 (BD Pharmingen #553371). Blast assay colonies and
hematopoietic ‘‘big mix’’ colonies were isolated and scored
using published methods (Choi et al., 1998; Fehling et al.,
2003; Kubo et al., 2004; D’Souza et al., 2005; Ivanova et al., 2006).
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